Cita APA

KV, L., C, v. d. W., D, K., I, D., JM, B., T, A., . . . AA, W. (2025). Catecholaminergic polymorphic ventricular tachycardia mediated by ryanodine receptor 2: A validated risk stratification.

Citación estilo Chicago

KV, Lieve, et al. Catecholaminergic Polymorphic Ventricular Tachycardia Mediated By Ryanodine Receptor 2: A Validated Risk Stratification. 2025.

Cita MLA

KV, Lieve, et al. Catecholaminergic Polymorphic Ventricular Tachycardia Mediated By Ryanodine Receptor 2: A Validated Risk Stratification. 2025.